Company: DNLI
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001714899-25-000170
Chunk: 390

Company: Denali Therapeutics Inc.
Filing Date: 2025-08-11
Form: 10-Q
Item: Part II, Item 1A
Chunk 390
---
 been filed separately with the SEC.

97

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

 DENALI THERAPEUTICS INC.Date:August 11, 2025By:/s/ Ryan J. WattsRyan J. Watts, Ph.D.President and Chief Executive Officer(Principal Executive Officer)Date:August 11, 2025By:/s/ Alexander O. SchuthAlexander O. Schuth, M.D.Chief Operating and Financial Officer(Principal Financial and Accounting Officer)

98